Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A

Crabb, Simon J., Howell, Melanie, Rogers, Helen, Ishfaq, Muhammad, Yurek-George, Alexander, Carey, Krystle, Pickering, Becky M., East, Phil, Mitter, Richard and Maeda, Satoko (2008) Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A. Biochemical Pharmacology, 76 (4). pp. 463-475.

Full text not available from this repository.

Abstract

We recently completed the total synthesis of spiruchostatin A, a depsipeptide natural product with close structural similarities to FK228, a histone deacetylase (HDAC) inhibitor (HDI) currently being evaluated in clinical trials for cancer. Here we report a detailed characterisation of the in vitro activity of spiruchostatin A. Spiruchostatin A was a potent (sub-nM) inhibitor of class I HDAC activity in vitro and acted as a prodrug, requiring reduction for activity. Spiruchostatin A was a potent (low nM) inhibitor of the growth of various cancer cell lines. Spiruchostatin A-induced acetylation of specific lysine residues within histones H3 and H4, and increased the expression of p21cip1/waf1, but did not induce acetylation of a-tubulin. Spiruchostatin A also induced cell cycle arrest, differentiation and cell death in MCF7 breast cancer cells. Like FK228, spiruchostatin A was both an inducer and substrate of the ABCB1 drug efflux pump. Whereas spiruchostatin A and FK228-induced protracted histone acetylation, hydroxamate HDI-induced short-lived histone acetylation. Using a subset of HDI-target genes identified by microarray analysis, we demonstrated that these differences in kinetics of histone acetylation between HDI correlated with differences in the kinetics of induction or repression of specific target genes. Our results demonstrate that spiruchostatin A is a potent inhibitor of class I HDACs and anti-cancer agent. Differences in the kinetics of action of HDI may be important for the clinical application of these compounds.

Item Type:	Article
Uncontrolled Keywords:	sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Science > School of Pharmacy
Depositing User:	Users 2731 not found.
Date Deposited:	20 Oct 2011 11:11
Last Modified:	24 Oct 2022 00:39
URI:	https://ueaeprints.uea.ac.uk/id/eprint/35113
DOI:	10.1016/j.bcp.2008.06.004

Actions (login required)

View Item